In summary, our findings reveal that the genetic abrogation of MST4 in mice fails to improve whole-body glucose tolerance or insulin sensitivity or mitigate the development of MASLD under conditions of nutritional stress. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.